Antihistamine and decongestant system

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8092831
APP PUB NO 20040091533A1
SERIAL NO

10291103

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to an oral pharmaceutical formulation that employs: (1) a compressed core containing a decongestant or pharmaceutically acceptable salt thereof; (2) a delayed release coating on the compressed core and (3) immediate release therapeutic amounts of a decongestant and an antihistamine.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddressTotal Patents
Andrx Pharmaceuticals, LLCDAVIE, FL42

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Kositprapa, Unchalee Davie, US 21 264
Sriwongjanya, Mongkol Davie, US 8 59

Cited Art Landscape

Patent Info (Count) # Cites Year
 
Taro Vit Industries, Ltd. (1)
5881926 Pharmaceutical compositions in semisolid form and a device for administration thereof 39 1993
 
SHAKER, GHASSAN I (1)
5660833 Anti-tussive composition 3 1996
 
Other [Check patent profile for assignment information] (3)
4777170 Method to prevent and treat the signs and symptoms of motion sickness 22 1987
5543405 Composition and method for weight reduction and long term management of obesity 45 1994
5859060 Timed release tablet comprising naproxen and pseudoepherine 25 1997
 
RICHARDSON-VICKS INC. (2)
4996047 Sustained release drug-resin complexes 123 1988
5141961 Process for solubilizing difficulty soluble pharmaceutical actives 25 1991
 
Gerhard Gergely (1)
5834019 Pharmaceutical formulation containing a hydrophobic active substance and an effervescent system 7 1996
 
VALEANT INTERNATIONAL BERMUDA (2)
5518730 Biodegradable controlled release flash flow melt-spun delivery system 240 1992
5869098 Fast-dissolving comestible units formed under high-speed/high-pressure conditions 59 1997
 
ALZA CORPORATION (4)
4801461 Pseudoephedrine dosage form 41 1987
4915952 Composition comprising drug, HPC, HPMC and PEO 24 1989
4915953 Dosage form for delivering acetaminophen or phenylpropanolamine 53 1989
5023076 Lamina comprising carboxyvinyl polymer 6 1990
 
SCHERING CORPORATION (8)
4282233 Antihistaminic 11-(4-piperidylidene)-5H-benzo-[5,6]-cyclohepta-[1,2-b]-pyridines 103 1980
4695591 Controlled release dosage forms comprising hydroxypropylmethylcellulose 49 1985
4659716 Antihistaminic 8-(halo)-substituted 6,11-dihydro-11-(4-piperidylidene)-5H-benzo[5,6]cyclohepta[1,2-b]pyridines 60 1986
4999189 Sustained release oral suspensions 52 1988
4990535 Pharmaceutical composition comprising loratadine, ibuprofen and pseudoephedrine 58 1989
5100675 Sustained release tablet comprising loratadine, ibuprofen and pseudoephedrine 57 1990
5869479 Treatment of upper airway allergic responses 58 1997
* 6114346 Treating sleep disorders using desloratadine 17 1999
 
Andrx Pharmaceuticals, LLC (2)
5654005 Controlled release formulation having a preformed passageway 73 1995
5922352 Once daily calcium channel blocker tablet having a delayed release core 23 1997
 
PURDUE PHARMA L.P. (1)
4834985 Controlled release pharmaceutical composition 245 1987
 
SRCHEM, INCORPORATED (1)
5288503 Cryogel oral pharmaceutical composition containing therapeutic agent 84 1992
 
IBAH, INC. (1)
5466865 Neomorphic ibuprofen and methods of using same 5 1993
 
ANDRX LABS, LLC (1)
5837379 Once daily pharmaceutical tablet having a unitary core 68 1997
 
SCHWARZ PHARMA, INC. (1)
4576645 Whipped gel composition 19 1984
 
Nortec Development Associates Inc. (2)
4800087 Taste-masked pharmaceutical compositions 118 1986
5084278 Taste-masked pharmaceutical compositions 126 1989
 
SUN PHARMACEUTICAL INDUSTRIES LIMITED (1)
* 6267986 Process for the preparation of a controlled drug delivery system containing pseudoephedrine and a long acting antihistamine 10 1999
 
BEND RESEARCH, INC. (2)
5876752 Use of interfacially-polymerized membranes in delivery devices 15 1993
5698220 Asymmetric membranes in delivery devices 69 1995
 
AVENTIS INC. (2)
4999226 Pharmaceutical compositions for piperidinoalkanol-ibuprofen combination 22 1989
4996061 Pharmaceutical composition for piperidinoalkanol-decongestant combination 36 1989
 
ELAN PHARMA INTERNATIONAL LIMITED (1)
4952402 Controlled release powder and process for its preparation 252 1988
 
MEDE VA PHARMACEUTICALS MANUFACTURING INC. (1)
4762709 Liquid prolonged release pharmaceutical formulations containing ionic constituents 49 1986
 
Analgesic Associates (5)
4749711 Cough/cold mixtures comprising non-steroidal anti-inflammatory drugs 16 1987
4749721 Cough/cold mixtures comprising non-steroidal anti-inflammatory drugs 17 1987
4749722 Cough/cold mixtures comprising non-steroidal anti-inflammatory drugs 19 1987
4839354 Cough/cold mixtures comprising non-steroidal anti-inflammatory drugs 18 1987
5025019 Cough/cold mixtures comprising non-steroidal anti-inflammatory drugs 18 1989
 
E. R. Squibb & Sons, Inc. (2)
4792452 Controlled release formulation 116 1987
5169638 Buoyant controlled release powder formulation 126 1991
 
BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA (1)
5691370 5-(2-imidazolinylamino)benzimidazole compounds useful as alpha-2-adrenoceptor agonists 14 1996
 
Plastic Dress-Up Co. (1)
5895663 Pseudoephedrine hydrochloride extended-release tablets 34 1997
 
R.P. SCHERER TECHNOLOGIES, INC. (1)
5858409 Hydrolyzed cellulose granulations for pharmaceuticals 43 1996
 
MERCK SHARP & DOHME CORP. (1)
* 5314697 Stable extended release oral dosage composition comprising loratadine and pseudoephedrine 38 1992
 
L'OREAL (1)
5795574 Use of an extract from a non-photosynthetic filamentous bacterium and composition containing it 21 1996
 
Menley & James Laboratories, Ltd. (1)
4692462 Compositions and method of controlling transdermal penetration of topical and systemic agents 39 1985
 
COLLEGIUM PHARMACEUTICAL, INC. (2)
* 2003/0035,839 Pharmaceutical composition for both intraoral and oral administration 55 2001
* 6827946 Compositions containing both sedative and non-sedative antihistamines 20 2001
 
WARNER-LAMBERT COMPANY LLC (3)
4632821 Magnesium trisilicate suitable for preparation of medicament adsorbates of decongestants 20 1985
4758424 Medicament adsorbates of decongestants with complex magnesium aluminum silicate and their preparation 41 1987
5385941 Salts/ion pairs of non-steroidal anti-inflammatory drugs in various dosage forms 10 1993
 
ANALGESIC ASSOCIATES, A NY CORP. (1)
4552899 Cough/cold mixtures comprising non-steroidal anti-inflammatory drugs 53 1984
 
The Procter & Gamble Company (8)
5431916 Pharmaceutical compositions and process of manufacture thereof 60 1993
5510389 Concentrated acetaminophen solution compositions 5 1994
5827852 Coated pharmaceutical compositions 40 1994
5458879 Oral vehicle compositions 108 1994
5560913 Pharmaceutical compositions 14 1995
5641512 Soft gelatin capsule compositions 32 1995
5560921 Chewable decongestant compositions 3 1995
5648358 Compositions and methods for treating respiratory disorders 8 1996
 
MAYNE PHARMA INTERNATIONAL PTY. LTD. (1)
5807579 Pseudoephedrine combination pharmaceutical compositions 74 1996
 
JOHNSON & JOHNSON CONSUMER INC. (2)
5919481 Fill material for soft gelatin pharmaceutical dosage form 15 1996
5891476 Tastemasked pharmaceutical system 17 1997
 
MEDEVA CALIFORNIA, INC. (1)
4650807 Antihistaminic compositions and methods containing pyridine derivatives 9 1985
 
FOREST LABORATORIES, INC. (1)
4369172 Prolonged release therapeutic compositions based on hydroxypropylmethylcellulose 242 1981
 
N.V. ORGANON (1)
5662936 Sugar-coated pharmaceutical dosage unit 5 1994
 
University of Massachusetts (1)
5595997 Methods and compositions for treating allergic rhinitis and other disorders using descarboethoxyloratadine 36 1994
 
FISONS CORPORATION (1)
4959219 Coating barriers comprising ethyl cellulose 56 1988
 
WYETH (4)
5024997 Palatable ibuprofen solutions 18 1990
5616621 Taste masking liquids 17 1995
5602182 Taste masking pseudoephedrine HCL containing liquids 11 1995
5759579 Pharmaceutical suspension systems 73 1996
 
Jame Fine Chemicals, Inc. (1)
5663415 Process for preparing antihistamine tannates 32 1996
 
CONCORDIA PHARMACEUTICALS, INC. (1)
5763449 Pleasant-tasting aqueous liquid composition of a bitter-tasting drug 21 1996
 
MCNEIL-PPC, INC. (17)
5004613 Oral sustained release pharmaceutical formulation and process 46 1989
5073380 Oral sustained release pharmaceutical formulation and process 49 1990
5215755 Rotogranulations and taste masking coatings for preparation of chewable pharmaceutical tablets 49 1991
5658589 Subcoated simulated capsule-like medicament 35 1991
5405617 Aliphatic or fatty acid esters as a solventless carrier for pharmaceuticals 24 1991
5272137 Aqueous pharmaceutical suspension for pharmaceutical actives 60 1992
5429825 Rotomelt granulation 49 1992
5296233 Dual subcoated simulated capsule-like medicament 26 1992
5451409 Sustained release matrix system using hydroxyethyl cellulose and hydroxypropyl cellulose polymer blends 46 1993
5489436 Taste mask coatings for preparation of chewable pharmaceutical tablets 108 1993
5409907 Aqueous pharmaceutical suspension for pharmaceutical actives 67 1993
5529783 Rotor granulation and coating of acetaminophen, pseudoephedrine, chlorpheniramine, and, optionally dextromethorphan 25 1994
5681577 Multiple action cold/sinus preparations 23 1995
5658919 Aqueous pharmaceutical suspension and process for preparation thereof 35 1996
5916590 Soft gelatin pharmaceutical dosage form 17 1996
5876759 Rapidly disintegrating pharmaceutical dosage form and process for preparation thereof 76 1997
5840337 Gelling agent for polyethylene gylcol 12 1997
 
TCF NATIONAL BANK (1)
5126145 Controlled release tablet containing water soluble medicament 137 1990
* Cited By Examiner

Patent Citation Ranking

Forward Cite Landscape

  • No Forward Cites to Display

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Jul 10, 2019
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jul 10, 2023
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00